Domestic pesticides sink into troughs

"This year, the insect pests were the lightest since 2002, and the sales volume of conventional conventional insecticides was the lowest in the past three years. Consumption of domestic high-end pesticides such as pymetrozine, nitenpyram and avermectin is not large. Most of the manufacturers of pharmaceutical preparations have suffered heavy losses due to sluggish sales,” said Feng, Manager of the Marketing Department of Yancheng Shuangcheng Agrochemical Co., Ltd., recently.

It is the unanimous feeling of many companies that the peak season is not prosperous and the impact of imported products has become increasingly fierce. Since the beginning of this year, the consumption of insecticides in our country has decreased by about 30% compared with previous years, and the sales of pharmaceuticals such as sulfasic acid, triazophos, insecticides, buprofezin, and pymetrozine have fallen more. In September, the traditional off-season arrival of pesticides, the market is expected to further decline, continued sluggish. Up to now, the price of the representative product avermectin refined powder has dropped to 450 yuan/kg, which is about 20% lower than the same period of last year, and caused the price of the derivative product of avividrine to fall.

Due to the extensive use of long-lived residues of chlorantraniliprole (Kangkuen) and flubendiamide (Rongge) in the prevention and control of rice pests in many countries in Southeast Asia, rice migratory pests have significantly decreased in southern China. The use of pesticides in rice is greatly reduced. Taking Jiangsu as an example, in the past, control of rice borer borer, rice borer borer, and rice leaf roller used to fight 3 to 4 doses in July. This year, it only takes 1 to 2 doses. The number of locusts and red spiders of spring peanuts in the North was reduced, the number of large-scale pesticide applications by farmers decreased, and the consumption of complex formulas such as beta-cypermethrin and avermectin was drastically reduced. In addition, the corn rough dwarf disease in summer corn field is lighter this year, and the number of prevention and treatment drugs is reduced, which also results in less demand for pesticide formulations such as imidacloprid, acetamiprid, and oxygen**. The use of food crops such as cotton and wheat has also significantly decreased this year. Most of the manufacturers of preparations of raw pharmaceuticals are slow-moving, and some products have kept prices down due to fierce competition in terminals, causing some raw pharmaceutical products to enter the off-season one month in advance.

At the same time as market capacity has decreased, the share of domestic mainstream insecticides such as chlorpyrifos, avermectin, insecticide list, and dichlorvos has gradually shrunk under the impact of imported products. Since the beginning of this year, the use of mainstream insecticides such as avermectin, methotrexate, pymetrozine and imidacloprid has emerged due to the emergence of new varieties of high-efficiency, low-level insecticides and the domestic market share of foreign patented insecticide products. gradually decreases. At present, the market share of imported pesticides in China has reached 25%. Kang Duan of DuPont Co., Ltd. in the Anhui market has 500 tons of sales, sales of more than 30 million yuan, 5 million acres of rice pest control area. In the depressed domestic market, the import of pesticides has become more and more powerful. This year, the use of bulk conventional pesticides has been reduced by 20% to 30%, while the import of high-end insecticides has increased by 30% to 40%.

However, in a dismal situation, prices of some insecticides, such as imidacloprid and cypermethrin, have been boosted due to exports. Because foreign imidacloprid enterprises can not compete with Chinese companies in terms of production cost and quality, so European and American countries and Southeast Asian countries have all purchased into China, making the export situation better than ever. It is estimated that the original drug exports will be around 6,000 tons this year, and there will be a certain gap in terms of domestic production. The current market price of imidacloprid raw drugs is 130,000 yuan (t price, the same below), which is 5,000 yuan higher than the 125,000 yuan in the first half of the year. In addition, due to rising foreign demand, cypermethrin exports a large amount, the current price rose from 98,000 yuan in the first half to 99,000 yuan. The cessation of chlorpyrifos in August resulted in a large number of companies. However, at the end of August, the volume of exports suddenly increased, making the original drug appear to be in a tight market. The current market price is 41,000 yuan, which is 2,000 yuan higher than the 39,000 yuan in the first half of the year.